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Abstract. Understanding how the gut microbiota is affected by diarrhea episodes may help explain alterations in
intestinal function among children in low-income settings. This study examined the composition of the gut microbiome
of Nicaraguan children both during diarrhea episodes and while free of diarrhea for at least 2 months. Relative abundances
of bacterial taxa, phylogenetic diversity, and species richness were determined by 16S amplicon sequencing and compared
between paired diarrhea and recovery samples. A total of 66 stools were provided by 25 children enrolled in a 1-year
cohort study of diarrhea etiologies. Children in our cohort had a mean age of 21.9 months; 64% were breast-fed, and
10% had received an antibiotic during the diarrhea episode. Overall, phylogenetic diversity and species richness did
not differ significantly between diarrhea and recovery stools. However, of children who had a bacterial enteropathogen
detected in any diarrhea stool, none experienced an increase in phylogenetic diversity in recovery, whereas of those in
whom no bacterial enteropathogens were detected in their diarrhea stool(s), 59% experienced an increase in phylogenetic
diversity in recovery (P = 0.008). This preliminary study suggests that recovery of the gut microbiota after a diarrhea
episode may take longer time than previously thought and may be pathogen specific.
INTRODUCTION
The gut microbiota serves important functions in the human
host, including enteropathogen displacement by colonization
competition, metabolism of energy substrates, and development
of enteric immunity.1 The gut microbiota undergoes a dynamic
process of colonization and development during the first
years of life. Soon after birth, the aerobic gut environment
encourages the growth of aerobes and facultative anaerobes
(such as Enterococcus, Streptococcus, and Lactobacillus).2,3
Decreasing oxygen levels favor the growth of obligate anaerobes
(such as Bifidobacterium, Clostridium, and Bacteroides).4,5
Weaning and introduction of solid foods further alter the gut
microbiota community structure, until the composition resem-
bles that of an adult later in childhood.4,6,7
Besides changes related to age, several other factors have
been reported to alter gut microbiota community structure,
including diet, birth route (vaginal versus Cesarean delivery),
exposure to antibiotics, nutritional status, genetic factors,
and diarrhea episodes.2,6,8 Diarrhea episodes have been
shown to be associated with an overall decrease in phylogenetic
diversity.9–12 Although modifications in the relative abundance
of taxa differ by study site, studies have shown increases in
the relative abundance of the phylum Proteobacteria and
decreases in Bifidobacterium and Lactobacillus during diarrhea
episodes.10–12 These alterations in the gut microbiota during
diarrhea episodes in the early years of lifemay have a substantial
impact on the subsequent development of the gut microbiota
and its related functions. These effects may be especially
important in developing world settings, where children com-
monly experience several diarrhea episodes per year.13
Although several studies have reported on changes in the
gut microbiota during diarrhea episodes in developing world
settings, such as Nicaragua, less is known about the composi-
tion and diversity of the gut microbiota during recovery after
diarrhea episodes. Understanding whether and how the gut
microbiota changes after a diarrhea episode may inform our
understanding of the potential impact of diarrhea episodes on
the functions of the gut microbiota. The goal of this study is
to compare features of the gut microbiota, including composi-
tion and diversity, during diarrhea episodes and after resolu-
tion of symptoms in young Nicaraguan children.
MATERIALS AND METHODS
Study design. Twenty-five children from a larger population-
based study of infectious diarrhea etiologies in León, Nicaragua,14
were selected to participate in this study. For the larger study,
children were visited in their households every 14 days between
January 25, 2010 and January 24, 2011 by field workers who
assessed diarrhea episodes and collected sociodemographic
information. Children were weighed, and weight-for-age per-
centiles were calculated using World Health Organization stan-
dards. Diarrhea was defined as an increase in stool frequency
to at least three loose stools per 24-hour period or as a sub-
stantial change in stool consistency (bloody, very loose, or
watery) after at least 3 diarrhea-free days. Stools were col-
lected from children who developed diarrhea during the diar-
rhea episode and from enrolled children without diarrhea in
the preceding 2 months who served as diarrhea-free controls.
Study population. Among the 826 children in the larger
study, 106 enrolled children without diarrhea in the preceding
2 months served as age-, sex-, and neighborhood-matched
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controls for children who developed diarrhea during the study.
Among these 106 children, 31 had previously provided at least
one stool during a diarrhea episode in the 1-year study and
were therefore eligible for this analysis. Six of the 31 children
had at least one stool that was not evaluable and so they
were removed from the analysis, which resulted in 25 children
selected for this study (Figure 1). Each child provided at least
one stool during diarrhea and one stool during recovery. Nine
children provided stool samples from multiple diarrhea epi-
sodes and 16 children provided stool samples from a single diar-
rhea episode, such that a total of 66 diarrhea and 25 recovery
stools were included. The study was approved by the Institu-
tional Review Boards of the National Autonomous University
of Nicaragua, León (UNAN-León) and the University of North
Carolina at Chapel Hill.
Stool collection. Stool specimens were obtained in a sterile
plastic container or from the child’s soiled diaper and were
transported within 2 hours from the household to the Micro-
biology Laboratory of UNAN-León at 4°C. Separate aliquots
were stored in 10% (w/v) suspension of stool with phosphate-
buffered saline (pH = 7.2) and stored at −20°C for micro-
biome analysis.
Detection of enteropathogens.Detection of enteropathogens
in stool samples was described in detail previously.14 In brief,
stools were analyzed by enzyme immunoassays to detect rota-
virus and adenovirus, and by real-time polymerase chain reac-
tion (PCR) for norovirus and sapovirus. Conventional culturing
techniques were used to detect the bacterial enteropathogens,
including Shigella spp., Salmonella spp., Campylobacter spp.,
and Escherichia coli. Positive E. coli cultures were assayed by
multiplex PCR for the following pathotypes: enteropathogenic
E.coli, enterotoxigenicE. coli, enteroaggregativeE. coli, entero-
invasive E. coli, and enterohemorrhagic E. coli, as described
by Vilchez.15 Direct microscopy was used for detection of the
parasitic enteropathogens, with concentration and acid-fast
staining for the detection of Cryptosporidium spp., as described
by Garcia.16
16S rDNA amplicon sequencing and sequencing data
analysis. DNA from stool samples was extracted using the
QIAmp DNA Stool kit (Qiagen, Hilden, Germany). Modifi-
cations were performed in the disruption step to ensure optimal
bacterial lysis, especially for gram-positive bacteria. In brief,
200 mg of sample was transferred to a microtube containing
0.2 g of autoclaved 11-μm-diameter glass beads (Sigma, St. Louis,
MO) and 1.4 mL of ASL buffer (Qiagen). Samples were then
homogenized in a TissueLyser II instrument (Qiagen) at 25 Hz
for 2 minutes according to the manufacturer’s protocol.
For amplicon library preparation, the V1-V2 hypervariable
region of the 16S rDNA was amplified from total bacterial
DNA isolated from each sample using a forward primer
composed of the Ion Torrent adapter A (5′-CCATCTCATC
CCTGCGTGTCTCCGACTCAG-3′), a 10-bp Ion Xpress™
barcode, unique to each sample (Life Technologies, Grand
Island, NY) and the universal bacterial primer 8F (5′-AGAG
TTTGATCCTGGCTCAG-3′). The reverse primer consisted
of the Ion Torrent trP1 adapter (5′-CCTCTCTATGGGCAG
TCGGTGAT-3′) (Life Technologies) followed by the reverse
bacterial primer 338R (5′-GCTGCCTCCCGTAGGAGT-3′).
PCR reactions contained 5–10 ng of DNA template,
2.5 units of HotStar Hi-fidelity DNA polymerase (Qiagen),
1 × HotStar Hi-Fidelity PCR buffer containing dNTPs
(Qiagen), and 0.6 μM of each primer. Reaction conditions
consisted of an initial denaturation for 5 minutes at 94°C
followed by 35 cycles of denaturing at 94°C for 60 seconds,
annealing at 57°C for 60 seconds, and extension at 72°C for
60 seconds, and a final extension of 72°C for 10 minutes.
No-template negative controls were amplified for all barcode
primer sets. PCR products were gel purified individually
using the E-Gel Electrophoresis System (Life Technologies)
and standardized before pooling. Purified samples were
pooled at equimolar concentrations and sequenced on an Ion
Torrent PGM (Life Technologies) using the Ion PGM 400
Sequencing Kit (Life Technologies) and the Ion 318 Chip Kit
(Life Technologies) in the Microbiome Core Facility at the
University of North Carolina at Chapel Hill.
Bioinformatic analysis of bacterial 16S amplicon data was
conducted using the Quantitative Insights Into Microbial
Ecology (QIIME) software pipeline17 as previously described.7,18
Sequencing data were demultiplexed and filtered for quality
control. Sequences were then aligned and clustered into oper-
ational taxonomic units (OTU) using the QIIME implemen-
tation of UCLUST.19 ChimeraSlayer was used for chimera
FIGURE 1. Selection of 25 child participants from larger population-based study.
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removal.20,21 OTUs were assigned to taxonomic categories at
a 97% similarity level to approximate species level. After
taxonomic assignment of OTUs, sequences were aligned and
phylogenetic trees were built with FastTree 2.1.3 (freely avail-
able at http://www.microbesonline.org/fasttree).22 Rarefaction
analysis was done using a random selection of 3,418 sequences
from each sample to ensure an even sampling depth and was
used to determine phylogenetic diversity and species rich-
ness. Beta diversity estimates were calculated within QIIME
using weighted and unweighted UniFrac distances23 between
samples at a depth of 3,418 sequences per sample.
Statistical analyses. Characteristics of children and their
diarrhea episodes were summarized by frequencies for categor-
ical variables and sample means for continuous variables. The
Wilcoxon signed-rank test was used to assess differences in the
relative abundances of bacterial taxa between paired diarrhea
and recovery samples. This analysis included only the stool
from the first diarrhea episode for children who experienced
multiple diarrhea episodes, to allow the longest interval between
diarrhea and recovery. Statistical significance was assessed
using a false discovery rate (FDR) correction to account for
multiple hypothesis tests. Paired t tests were used to compare
phylogenetic diversity and species richness between diarrhea
and recovery stools. This analysis was stratified by age group,
as phylogenetic diversity and species richness are known to
increase with age.24,25 As above, we included only the stool
from the first diarrhea episode for children who experienced
multiple diarrhea episodes. Spearman correlation coefficients
were calculated to estimate the correlations between phyloge-
netic diversity or species richness and age, and between phylo-
genetic diversity or species richness and time since the last
diarrhea episode. Fisher exact test was used to compare changes
in phylogenetic diversity and species richness between diarrhea
episodes and recovery by enteropathogen category. Fisher exact
test was also used to compare changes in phylogenetic diversity
and species richness between diarrhea episodes and recovery
by category of enteropathogen detected in recovery stools. In
these analyses, changes in phylogenetic diversity and species
richness were categorized as either increased or decreased. We
estimated associations between age, sex, time between diarrhea
and recovery stool collection, antibiotic receipt, breast-feeding,
and bottle-feeding with phylogenetic diversity and species rich-
ness using linear regression models with generalized estimating
equations to account for clustering on the level of the indi-
vidual. These analyses were performed using SAS versions 9.3
and 9.4 (Cary, NC).
RESULTS
Characteristics of children and diarrhea episodes. The
25 children included in the study had a mean age of
21.9 months, 64% were receiving breast milk, and 4% had
a weight-for-age percentile below the 5th percentile. Among
the 41 diarrhea episodes experienced by the children, 10%
were treatedwith an antibiotic and 5% resulted in hospitalization
(Table 1). Recovery stool samples were collected on average
189 days (standard deviation [SD] = 77 days, range = 62–335
days) after the most recent diarrhea episode.
Enteropathogens detected among stool samples. At least
one enteropathogen was detected in 61% of diarrhea stools.
The proportions of the 41 diarrhea stools inwhich viral, bacterial,
parasitic, or mixed category enteropathogens were detected
were 32%, 15%, 2%, and 12%, respectively (Table 1). Viral
enteropathogens identified in diarrhea stool samples included
norovirus (n = 13), sapovirus (n = 5), and rotavirus (n = 1).
Bacterial enteropathogens identified in diarrheal stool samples
included enteropathogenic E. coli (n = 4), enterotoxigenic
E. coli (n = 3), enterohemorrhagic E. coli (n = 1), Shigella
flexneri (n = 1), and Campylobacter spp. (n = 1). Parasitic
enteropathogens identified in diarrheal stool samples included
Giardia lamblia (n = 1), Cryptosporidium spp. (n = 1), and
Entamoeba histolytica/dispar (n = 3).
Enteropathogens were also detected in 44% of the recovery
stools. The proportions of the 25 recovery stools in which
viral, bacterial, parasitic, or mixed category enteropathogens
were detected were 12%, 20%, 4%, and 8%, respectively.
Enteropathogens identified in recovery stool samples included
norovirus (n = 3), adenovirus (n = 1), enteropathogenic E. coli
(n = 3), enterotoxigenicE. coli (n = 3), enteroaggregativeE. coli
(n = 1),G. lamblia (n = 1), Cryptosporidium spp. (n = 1) and E.
histolytica/dispar (n = 1).
Microbiome characterization of diarrhea and recovery
stools. After filtering for quality and length, a total of
541,186 sequences (7,313 reads ± 4,598 per stool sample) were
assigned to 3,211 OTUs at ≥ 97% similarity, clustering into
242 genera, 116 families, 53 orders, 27 classes, and 13 phyla.
The microbial composition of both diarrhea and recovery
stools was dominated by the phylum Firmicutes, followed by
Proteobacteria, Cyanobacteria, Actinobacteria, Bacteroidetes,
and Verrucomicrobia (Figure 2). Members of the phyla TM7,
Fusobacteria, Tenericutes, Chloroflexi, Thermi, Spirochetes,
and Synergistetes were detected at levels below 1.0%.
In further analysis, we included only the first diarrhea stool for
children who experienced multiple diarrhea episodes. At the
phylum level, there was an overrepresentation of the phylum
Fusobacteria in diarrhea (relative abundance = 0.26%, SD =
0.47%) compared with recovery stools (0.06%, SD = 0.15%)
(Wilcoxon signed-rank test, unadjustedP= 0.0036; FDRadjusted
TABLE 1
Characteristics of children and diarrhea episodes
Characteristics of children (N = 25)
Mean age in months* 21.9 (SD = 12.4)
Gender, % female 48% (12/25)
Receiving breast milk* 64% (16/25)
Weight-for-age percentile†, % > 5th percentile 96% (24/25)
Mother completed any secondary education 76% (19/25)
Poverty index, % with basic needs met 88% (22/25)
Indoor toilet 84% (21/25)
Non-dirt floor 96% (24/25)
Mean diarrhea episodes per year
(stools collected)
2.6 (SD = 0.8)
Characteristics of diarrhea episodes (N = 41)
Maximum number of stools per 24 hours,
mean (SD)
3.6 (SD = 1.2)
Fever 27% (11/41)
Vomiting 24% (10/41)
Bloody diarrhea 0% (0/41)
Hospitalized 5% (2/41)
Received antibiotic for diarrhea 10% (4/41)
Enteropathogen detected 61% (25/41)
Viral enteropathogen detected 32% (13/41)
Bacterial enteropathogen detected 15% (6/41)
Parasitic enteropathogen detected 2% (1/41)
Mixed category infection detected 12% (5/41)
SD = standard deviation.
*At the time of first diarrhea episode.
†World Health Organization weight-for-age percentile on study entry.
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P = 0.05). Likewise, the phylum Bacteroidetes was more abun-
dant in diarrhea (4.5%, SD = 4.2%) compared with recovery
stools (2.7%, SD = 3.1%) (Wilcoxon signed-rank test, unadjusted
P = 0.0316; FDR adjusted P = 0.16). Figure 2 shows the relative
abundances of phyla and families identified in the first diarrhea
stool versus recovery stool.
At the genus level, unclassified genera in the family Rickene-
llaceae within the Bacteroidetes phylum, two genera within the
Cyanobacteria phylum, 11 genera within the Firmicutes phylum,
two genera within the Fusobacteria phylum, and seven genera
within the Proteobacteria phylum were over- or underrepre-
sented in the diarrhea and recovery samples (Wilcoxon signed-
rank test, unadjusted P < 0.05) (Figure 3). However, only one
genus, Cetobacterium, remained statistically significant after con-
trolling for multiple comparisons (FDR adjusted P = 0.0217).
Cetobacterium and Fusobacterium in the phylum Fusobacteria
were overrepresented in the diarrhea group: 13.5- and 4.2-fold
(e2.60 and e1.43), respectively (Figure 3). Achromobacter, a Beta-
proteobacteria of the Burkholderiales order, and Lactobacillus,
a Firmicutes genus that could be considered a marker of a
healthy gut microbiota, were 14.3- and 3.3-fold (e2.66 and e1.19)
overrepresented in the diarrhea group. Conversely, four out
of six genera overrepresented in the recovery group (Dorea,
Blautia, Dialister, and Sporobacterium WAL_1855D) were of
the order Clostridiales in the phylum Firmicutes.
Phylogenetic diversity and species richness. For children
under 2 years of age, the mean phylogenetic diversity and
species richness were lower in recovery stools as compared
with diarrhea stools, but the detected differences did not
reach statistical significance. Among children aged 2–5 years,
mean phylogenetic diversity and species richness values were
significantly lower in recovery stools as compared with diarrhea
stools (Figure 4). Phylogenetic diversity increased with age
(Spearman correlation coefficient [ρ] = 0.27, P = 0.0253); simi-
larly, species richness increased with age (ρ = 0.27, P = 0.0273).
Neither phylogenetic diversity nor species richness in recovery
increased with time since the most recent diarrhea episode
(ρ = −0.12, P = 0.3258; ρ = −0.17, P = 0.1662, respectively).
Among the eight children who experienced any diarrhea
episode in which a bacterial enteropathogen was detected,
none experienced an increase in phylogenetic diversity in
recovery; conversely, among the children who experienced
diarrhea episode(s) in which no bacterial enteropathogens
were detected, 59% (10/17) experienced an increase in phy-
logenetic diversity in recovery (P = 0.008). We did not find
FIGURE 2. Relative abundances of phyla and families detected in the first diarrhea stool vs. recovery stool.
FIGURE 3. Ratio of the natural log of relative abundances of genera
that differed* between the first diarrhea stool vs. recovery stool. *P <
0.05 unadjusted Wilcoxon signed-rank test. Using Wilcoxon signed-
rank test adjusted by false discovery rate (FDR), only the difference
in the relative abundance of Cetobacterium was statistically significant
(P = 0.0217).
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an association between the change in phylogenetic diversity
in diarrhea and recovery and the detection in any diarrhea
stool of either viral (P = 1.0), parasitic (P = 1.0) or mixed-
category enteropathogens (P = 1.0). For species richness, we
observed the same relationships as above for phylogenetic
diversity. Among the children who experienced any diarrhea
episode in which a bacterial enteropathogen was detected,
13% (1/8) experienced an increase in species richness in
recovery, as compared with 59% (10/17) in children who did
not experience any diarrhea episodes in which a bacterial
enteropathogen was detected (P = 0.042). Also, we did not
find an association between the change in species richness
in diarrhea and recovery and the detection of either viral
(P = 1.0), parasitic (P = 0.34), or mixed category entero-
pathogens (P = 0.18) in any diarrhea stool. Further, in recov-
ery, there was no association between the detection of any
category of enteropathogen in recovery stools and change in
either phylogenetic diversity (P = 0.66 for bacterial; P = 1.0
for viral; P = 1.0 for parasitic; and P = 0.50 for mixed) or
species richness (P = 0.41 for bacterial; P = 0.57 for viral;
P = 1.0 for parasitic; and P = 0.49 for mixed).
In linear regression modeling, while increasing age was
associated with an increase in phylogenetic diversity and species
richness, there were no associations between sex, time between
diarrhea and recovery stool collection, antibiotic receipt, and
breast-feeding or bottle-feeding and these outcomes (results
not shown).
DISCUSSION
A growing body of evidence shows that the gut microbiota,
which develops during early life, has functions important to
human health. Although prior studies have examined changes
in gut microbiota during diarrhea episodes, less is known
about changes during recovery. In our study, we did not find
an increase in phylogenetic diversity or species richness of the
gut microbiome in children after at least 2 months after reso-
lution of symptoms from a diarrhea episode. These findings
suggest that diarrhea episodes may be more disruptive to the
gut microbiota than previously thought. As has been reported
previously,7,24,25 we found that phylogenetic diversity trended
upward with age. In this study, we found that children without
bacterial enteropathogens detected in their diarrheal stool
were more likely to have a higher phylogenetic diversity in
recovery. It is possible that the action of bacterial entero-
pathogens continues undetected after resolution of symp-
toms from diarrhea episodes, prolonging the time needed
for a complete recovery of the gut microbiota. Since diversity
was lower in recovery in all cases in which a bacterial entero-
pathogen was detected, the mechanisms by which these path-
ogens impact microbial diversity are likely different and may
include toxin production and invasion of tissues through dif-
ferent mechanisms.
Further, we found that microbiome composition differed
during diarrhea episodes and recovery. Recovery stools had a
lesser relative abundance of Lactobacillus, thought to be a
marker of a healthy microbiome.26,27 While this finding was
unexpected, a previous study of Indian children found that
the abundance of Lactobacillus species increased at the end
of diarrhea episodes and then decreased after 3 months of
recovery.28 Also, as compared with diarrhea stools, recovery
stools had a greater relative abundance of genera of the order
Clostridiales (Dorea, Blautia, Dialister, and Sporobacterium
WAL_1855D). Some of these Clostridiales genera are known
to produce the short-chain fatty acid, butyrate, which pro-
motes the growth of the intestinal epithelium. While Clostridium
difficile was not found to be more abundant in recovery stools,
it is possible that the same gut environment in recovery that
promotes the colonization of the other Clostridiales genera may
also support colonization by C. difficile. A previous study
followed microbiome composition in children treated for cholera
until 28 days after the onset of diarrhea and also found an
increase in Clostridiales.29 Overall, the decrease inLactobacillus,
a facultative anaerobe, and the increase in anaerobicClostridiales
genera may reflect decreasing oxygen availability in the gut
during recovery as compared with a diarrhea episode.
A limitation of this study is that it was performed with 25 chil-
dren; our findings should be confirmed with a larger study. Also,
we acknowledge that 16S sequencing may underestimate bifi-
dobacterial taxa30; our approach could have been strengthened
by the addition of primers specific to known members of this
genus. Further, we acknowledge that recent evidence shows that
detection of bacterial enteropathogens, particularly, Shigella
spp., may be increased through the use of molecular diagnostic
techniques over conventional bacterial culture.31 Therefore,
we may have underdetected bacterial enteropathogens in our
FIGURE 4. Phylogenetic diversity and species richness in diarrhea and recovery stools by age group (whiskers indicate the ranges of phyloge-
netic diversity or species richness values; *P < 0.01 paired t test).
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samples. Finally, because we did not collect a sample before the
first diarrhea episode, we were unable to determine whether the
microbiome composition returned to a “pre-diarrhea” state or
attaineda“newnormal”composition.
Overall, this study suggests that diarrhea episodes may
have a longer effect on changes in gutmicrobiota than previously
thought, and these effects may be pathogen specific. Future
studies may identify the functional implications of these
changes and potential interventions to limit the burden of
diarrheal disease.
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